KWM

Kanen Wealth Management Excoriates Fossil Board of Directors and Management for Unacceptably Slow Restructuring Plan

Retrieved on: 
Thursday, April 18, 2024
Debt-to-GDP ratio, Sale, TAG, Skin, Transform, KWM, FOSL, Anxiety, Fossil Group

Judging by the actions of the board and management, there is a lack of urgency in executing its strategic initiatives and returning to profitability.

Key Points: 
  • Judging by the actions of the board and management, there is a lack of urgency in executing its strategic initiatives and returning to profitability.
  • To date, we have little to show as a result of the Transform and Grow plan (TAG).
  • Fossil shares are down approximately 80% since the plan was announced in February 2023.
  • Management needs to take a faster approach in reducing expenses, identify profitable segments, and implement these measures in a rapid cadence.

Kanen Wealth Management Issues Letter To Real Good Food Company, Inc.’s Board of Directors

Retrieved on: 
Friday, December 22, 2023
RGF, Common stock, Letter, Common, Food, KWM, Real, Betrayal

CORAL SPRINGS, Fla., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Kanen Wealth Management, LLC, owner of approximately 9.2% of the Real Good Food Company, Inc.’s (NASDAQ: RGF) (the “Company”) Class A Common Stock outstanding, issued a letter to the Company’s board of directors warning against a potential “take private” offer and transaction that would deprive long-suffering shareholders of the appropriate premium for their shares.

Key Points: 
  • The full text of the letter is below:
    Dear Mr. Bryan Freeman and RGF Directors,
    Kanen Wealth Management, LLC (“KWM”) is one of the largest shareholders of the Real Good Food Company, Inc. (NASDAQ: RGF) (“RGF” or the “Company”), owning over 1.8 million shares, representing approximately 9.2% of the Company’s outstanding Class A Common Stock.
  • Given our ownership of the Company, we recently requested representation on the Company’s board of directors (the “Board”) but were rejected.
  • We note that the current Board has served since 2020 and during that time over 85% of shareholder value has been destroyed!
  • Based on our interaction with Mr. Bryan Freeman, we feel it’s appropriate to warn the current management and Board against conducting a potential management buyout of remaining shares not owned by management and the Board.

David Kanen, president of Kwm llc issues letter to the eGain board calling for the formation of a special committee and sale of egan. He also excoriates CEO Ashu Roy.

Retrieved on: 
Monday, December 4, 2023
ZERO, Sale, CFO, Software as a service, Growth, IPO, KWM, ASHU, Management

Under CEO Ashu Roy’s leadership, EGAN’s stock is down approximately 40% since the Company’s IPO 24 years ago in 1999 versus the NASDAQ gain of approximately 500%.

Key Points: 
  • Under CEO Ashu Roy’s leadership, EGAN’s stock is down approximately 40% since the Company’s IPO 24 years ago in 1999 versus the NASDAQ gain of approximately 500%.
  • We believe the problem is Ashu Roy and he has failed shareholders!
  • One can debate the above as opinion or conjecture, however the Company’s failure to close new deals up until recently corroborates this feedback.
  • Earlier this year, KWM made several introductions via email to private equity firms interested in acquiring EGAN.

Lifeway Foods® Announces Annual Meeting Results and Provides Update to Shareholders

Retrieved on: 
Friday, June 16, 2023
Circuit court, Communication, Financial adviser, Marketing, Proposal 2, Lifeway, 2015 Michigan Proposal 1, Audit, Annual, Annual Meetings of the International Monetary Fund and the World Bank Group, Skin, KWM, History, Kefir, Annual general meeting, Yogurt, Growth, Health, Lifeway Foods, Letter, Circuit Court of Cook County, Security (finance), Management, Video game

MORTON GROVE, Ill., June 16, 2023 /PRNewswire/ -- The Board of Directors (the "Board") of Lifeway Foods, Inc. (Nasdaq: LWAY) ("Lifeway" or the "Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced the results of its 2023 Annual Meeting of Shareholders (the "Annual Meeting") and provided other updates to shareholders.

Key Points: 
  • At the Annual Meeting held on June 15, 2023, shareholders supported Proposal 1, electing the Company's eight nominees to the Board.
  • Notably, a leading independent shareholder advisory firm, Institutional Shareholder Services Inc., recommended that shareholders vote for the Company's eight director nominees.
  • In connection with this engagement, the independent members of the Board stated:
    "We are always open to considering all available avenues to maximize shareholder value.
  • Chief Executive Officer Julie Smolyansky and the entire leadership team are successfully executing our Lifeway 2.0 strategy to optimize growth, productivity and profitability.

David Kanen, President of KWM writes letter to CEO and board of LWAY calling for a sale of the company. Mr Kanen also stated his intention to vote his shares in favor of the director slate proposed by Edward and Ludmilla Smolansky who own 31.3% of LWAY sh

Retrieved on: 
Thursday, June 8, 2023
Real, WE, Employment, Lifeway, KWM, Sale, Milk, Standstill, Growth, Kefir, Management

While we are not legal experts, the evidence seems overwhelming that you have failed to act in good faith.

Key Points: 
  • While we are not legal experts, the evidence seems overwhelming that you have failed to act in good faith.
  • We have spent a considerable amount of time reviewing Lifeway’s governance, operations, sales strategy, products, and executive compensation.
  • We believe the current board and CEO have been mis-managing the business and not acting in the best interest of its shareholders.
  • We further believe the company’s stock is undervalued, but cannot realize a greater value with the current CEO and board.

Greenberg Traurig Adds Experienced UK Financial Regulation Lawyer Tim Dolan in London

Retrieved on: 
Tuesday, January 31, 2023
LL.B, University, Reed Smith, Prudential Regulation Authority, LLP, Financial Services Authority (United Kingdom), Bank, Knowledge, KWM, B.A, Andrew Mellon, BNY Mellon, SJ, Greenberg Traurig, Financial Conduct Authority, Financial Regulatory Authority, Lawyer, Security (finance), Financial adviser

LONDON, Jan. 31, 2023  /PRNewswire-PRWeb/ -- Global law firm Greenberg Traurig, LLP further expands its London office with the addition of Tim Dolan as a shareholder focused on UK and European financial regulatory matters. Dolan joins from Reed Smith, where he was a partner in its financial regulatory group.

Key Points: 
  • -Global law firm Greenberg Traurig, LLP further expands its London office with the addition of Tim Dolan as a shareholder focused on UK and European financial regulatory matters.
  • LONDON, Jan. 31, 2023 /PRNewswire-PRWeb/ -- Global law firm Greenberg Traurig, LLP further expands its London office with the addition of Tim Dolan as a shareholder focused on UK and European financial regulatory matters.
  • Dolan joins from Reed Smith, where he was a partner in its financial regulatory group.
  • Dolan brings key regulatory experience to his practice, having previously worked for international financial regulators in New Zealand and with the UK's Financial Services Authority.

Investment Confidence in Icon Group to Drive Next Phase of Global Growth With EQT Infrastructure Investment

Retrieved on: 
Friday, November 19, 2021
Patient, Cancer, Radiology, Goldman Sachs, Technology, Industry, Morgan Stanley, PricewaterhouseCoopers, Philip M. Parker, EQT, NYSE, Google Images, Partnership, QIC, Group, GS, COVID-19, History, City, Private equity, Research, Investment, Deloitte, Radiation, Varian Medical Systems, KWM, LinkedIn, Pharmacy, Growth, APAC, Renewable energy, Security (finance), Pharmaceutical industry

BRISBANE, Australia, Nov. 19, 2021 /PRNewswire/ -- Icon Group has today announced it will enter the next phase of global expansion of its transformative integrated cancer care model following the investment of global investment organisation EQT.

Key Points: 
  • BRISBANE, Australia, Nov. 19, 2021 /PRNewswire/ -- Icon Group has today announced it will enter the next phase of global expansion of its transformative integrated cancer care model following the investment of global investment organisation EQT.
  • The new investment will allow the Group to continue to further expand its successful model intoAsiaand deeper into the northern hemisphere.
  • Mark Middleton, global CEO Icon Group added: "Icon's commitment to innovation and the delivery of cancer care is limitless.
  • Now, we can drive the next phase of global growth and market leadership through further investment in critical infrastructure and cutting-edge technologies."

Investment Confidence in Icon Group to Drive Next Phase of Global Growth With EQT Infrastructure Investment

Retrieved on: 
Friday, November 19, 2021
Patient, Cancer, Radiology, Goldman Sachs, Technology, Industry, Morgan Stanley, PricewaterhouseCoopers, Philip M. Parker, EQT, NYSE, Google Images, Partnership, QIC, Group, GS, COVID-19, History, City, Private equity, Research, Investment, Deloitte, Radiation, Varian Medical Systems, KWM, LinkedIn, Pharmacy, Growth, APAC, Renewable energy, Security (finance), Pharmaceutical industry

BRISBANE, Australia, Nov. 18, 2021 /PRNewswire/ -- Icon Group has today announced it will enter the next phase of global expansion of its transformative integrated cancer care model following the investment of global investment organisation EQT.

Key Points: 
  • BRISBANE, Australia, Nov. 18, 2021 /PRNewswire/ -- Icon Group has today announced it will enter the next phase of global expansion of its transformative integrated cancer care model following the investment of global investment organisation EQT.
  • The new investment will allow the Group to continue to further expand its successful model intoAsiaand deeper into the northern hemisphere.
  • Mark Middleton, global CEO Icon Group added: "Icon's commitment to innovation and the delivery of cancer care is limitless.
  • Now, we can drive the next phase of global growth and market leadership through further investment in critical infrastructure and cutting-edge technologies."

Kanen Nominates Five Highly-Qualified Candidates for Election to the 1847 Goedeker Inc. Board at 2021 Annual Meeting

Retrieved on: 
Thursday, September 9, 2021

Mr. Kanen served as an independent advisor at Aegis Capital, Inc., a full service securities broker-dealer, from 2012 to 2016.

Key Points: 
  • Mr. Kanen served as an independent advisor at Aegis Capital, Inc., a full service securities broker-dealer, from 2012 to 2016.
  • Mr. Kanen served as a retail and institutional financial advisor at A.G. Edwards & Sons, Inc., a full service securities broker-dealer, from 1992 to 2004.
  • Mr. Kanen has served on the Board of Build a Bear Workshop Inc., a global retail company, since July 2019.
  • Ms. Liu served on the Board of Kindred Biosciences, Inc., a veterinary biopharmaceutical company, from February 2021 to August 2021.